Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERAP2 | Q6P179 | 8/20 | 0.60 |
| ▸ | ECE1 | P42892 | 5/20 | 0.53 |
| ▸ | ERAP1 | Q9NZ08 | 6/20 | 0.51 |
| ▸ | ANPEP | P15144 | 1/20 | 0.51 |
| ▸ | IL1RN | P18510 | 6/20 | 0.51 |
| ▸ | MMP1 | P03956 | 2/20 | 0.50 |
| ▸ | MMP2 | P08253 | 3/20 | 0.49 |
| ▸ | MMP9 | P14780 | 2/20 | 0.49 |
| ▸ | MMP8 | P22894 | 2/20 | 0.49 |
| ▸ | ACE | P12821 | 2/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29802507 | 0.92 | ERAP2 (0.54) | ERAP2ECE1ERAP1ANPEPACE | |
| SCHEMBL30166489 | 0.92 | ECE1 (0.61) | ERAP2ECE1ERAP1ANPEPIL1RN | |
| SCHEMBL30436333 | 0.92 | ECE1 (0.61) | ERAP2ECE1ERAP1ANPEPIL1RN | |
| SCHEMBL30974109 | 0.91 | ERAP2 (0.58) | ERAP2ECE1ERAP1IL1RN | |
| SCHEMBL29519893 | 0.90 | ERAP2 (0.58) | ERAP2ECE1ERAP1ANPEPIL1RN | |
| SCHEMBL31126208 | 0.90 | ERAP2 (0.51) | ERAP2ECE1ERAP1ANPEPIL1RN | |
| SCHEMBL31031484 | 0.90 | ERAP2 (0.52) | ERAP2ECE1ERAP1IL1RNMMP1 | |
| SCHEMBL29663506 | 0.89 | GHSR (0.52) | ERAP2ECE1ERAP1ANPEPIL1RN | |
| SCHEMBL30988538 | 0.89 | ERAP2 (0.56) | ERAP2ECE1ERAP1ANPEPIL1RN | |
| SCHEMBL30561494 | 0.89 | ERAP2 (0.56) | ERAP2ECE1ERAP1ANPEPIL1RN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114409730-A | Active peptide, active peptide composition and application of active peptide composition in preparation of product with anti-aging effect | 深圳科兴药业有限公司 | 2022-04-29 | — | — | CN | disclosed |